Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02132520 · ClinicalTrials.gov registry record · NA

A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training

A NA study of Stroke and Hemiparesis, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT02132520 is a NA study of Stroke and Hemiparesis that has completed, run by University of Minnesota. The registered enrollment target is 3 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02132520, a NA study of Stroke and Hemiparesis, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether the combination of low frequency repetitive transcranial magnetic stimulation (rTMS) and motor-imagery-based brain computer interface (BCI) training is effective for enhancing motor recovery after stroke. The PI's hypothesis is that, in comparison with traditional physical therapy alone, subjects receiving supplementary rTMS and BCI training will show greater functional improvements in hand motor ability over time as well as recovery of normal motor connectivity patterns.

Conditions Studied

Interventions

  • DEVICE rTMS
  • BEHAVIORAL BCI Training

Study Locations (1)

Minnesota

  • Clinical and Translational Science Institute - Minneapolis

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2014-03
Est. Completion 2017-06
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT02132520

The ClinicalTrials.gov registry entry for NCT02132520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which rTMS is the first listed.

NCT02132520 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02132520 about?

NCT02132520 is a clinical study titled "A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training". The purpose of this study is to determine whether the combination of low frequency repetitive transcranial magnetic stimulation (rTMS) and motor-imagery-based brain computer interface (BCI) training is effective for enhancing motor recovery after stroke. The PI's hypothesis is that, in comparison w...

What is the current status of trial NCT02132520?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2014-03. Estimated completion is 2017-06.

What conditions does trial NCT02132520 study?

This clinical trial studies the following conditions: Stroke, Hemiparesis.

What interventions are being tested in trial NCT02132520?

The interventions under investigation include: rTMS (DEVICE), BCI Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02132520?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02132520 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.